Boston Consulting Group report: alternative protein industry takes cues from EV industry for growth

Plus, Big Idea Ventures dives into plant-based seafood, Better Meat Co. scores landmark FDA approval for Rhiza, and more!

So many fantastic stories this week that, once again, it’s difficult to know what to bring you first! Check out our website to read much more than we can list below.

First up, though, it has to be the news from a friend of the platform that delighted us. The plant-based protein sector received a significant boost this week with a 'No Questions Letter' from the FDA for this company’s Rhiza mycoprotein.

The Royal Agricultural University (RAU) published a report titled ‘Culture Clash? What cultured meat could mean for UK farming’, which examines how cultured meat might affect UK farmers.

Meanwhile, two University of Waterloo students are leveraging AI to understand fish cell growth for large-scale, sustainable cultured seafood production. Their research aims to optimize cell behavior, create fish species profiles, and develop models for animal-free growth media and efficient cell production.

Alt-meat struggles to compete with real meat on price and taste. Learning from electric vehicles, the industry needs innovation, investment, and government support to bring down costs and create tastier options. This could revolutionize food with sustainable, customized protein, according to one industry consultant.

We were also excited to hear that VBites has acquired Alternative Stores, boosting their online presence and product range. This move could benefit both companies and smaller vegan brands, potentially leading to a more competitive and accessible vegan market.

Dutch supermarkets are ramping up plant-based protein options, with a goal of 60% by 2030. This follows an animal rights campaign and reflects changing consumer preferences. This shift benefits animal welfare, sustainability, and offers consumers more choices.

As usual, there’s much more online, and don’t forget to follow our LinkedIn page for the stories as they go live…

Not on the list

With increasing consumer demand for healthier, less-processed alt protein products that have short lists of recognizable ingredients, is ‘clean label’ the driving force for companies wanting a share of this marketplace? Or is the term itself becoming merely a marketing tool? The answer, as Louise Davis discovers, lies somewhere in the middle

Exploring how New Wave Biotech’s AI software aims to revolutionize bioprocess development

New Wave Biotech’s AI software acts as a virtual lab, simulating vast numbers of experiments to dramatically reduce development time and costs. The result? Cheaper, more accessible alternative proteins, and in doing so accelerating their journey to becoming a mainstream sustainable food source. The company’s CEO & Co-founder, Zoe Yu Tung Law explains more

The Future of Protein Production Amsterdam is Europe's meeting place for accelerating the commercialization of alternative proteins. The conference and exhibition will showcase more than 40 exhibitors, over 100 speakers and bring together more than 400 people.

The preliminary agenda is out now. Book now to get the ‘Early Bird’ rate and save more than €300!

Are you feeling the pinch on funding your alt-protein startup? This webinar sponsored by Ginkgo Bioworks will smash through traditional barriers, exploring creative capital solutions to fuel your innovation. Discover alternative pathways like grant funding for R&D, pre-sales agreements to gauge market interest, and crowdfunding platforms to leverage passionate consumers. Government funding initiatives and industry accelerators will also be on the table, offering expert guidance and potential non-dilutive capital. Learn how to craft an alt-protein specific pitch deck that resonates with investors, and explore alternative debt financing options.

 

🎙️💡Listen to the latest episode now! In this show, Unlocking Growth Smart Investments For Developing And Processing Alternative Proteins, guests including Jason Tucker, Karsten Schellhas, Brian Jacobson, Steve Radke, Juan Martinez, and Dan Wolff discuss the high capital expenditures required for setting up production facilities and the uncertainties in market demand that can deter investors. The experts share insights on optimizing production through intelligent equipment choices and the benefits of partnering with experienced suppliers.🎙️💡

Did you know that over 10,000 subscribers receive this weekly newsletter, with open rates and clicks well above the industry average?

Do you want us to share your exciting developments with this rapidly growing community? Maybe you'd like to write an article for our website: a column, an Innovation Insight, or a thought-leadership piece...?

If the answer is ‘yes’ to any of those questions, then email us at [email protected]